Clinical trial
EValuation Of NGAL in Early and eVolving Acute kidnEy Injury
NCT00445809 is registered in ClinicalTrials.gov with Abbott RDx Cardiometabolic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EValuation Of NGAL in Early and eVolving Acute kidnEy Injury
- Lead sponsor
- Abbott RDx Cardiometabolic
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- April 30, 2009
- Enrollment
- 355 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
kidney failure, acute